# Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?

> **NCT00814281** · NA · COMPLETED · sponsor: **Marywood University** · enrollment: 24 (estimated)

## Conditions studied

- Airway Inflammation

## Interventions

- **OTHER:** placebo
- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT00814281
- **Lead sponsor:** Marywood University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2009-03
- **Final completion:** 2009-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2009-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814281, "Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00814281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*